[go: up one dir, main page]

IN2014DN09713A - - Google Patents

Info

Publication number
IN2014DN09713A
IN2014DN09713A IN9713DEN2014A IN2014DN09713A IN 2014DN09713 A IN2014DN09713 A IN 2014DN09713A IN 9713DEN2014 A IN9713DEN2014 A IN 9713DEN2014A IN 2014DN09713 A IN2014DN09713 A IN 2014DN09713A
Authority
IN
India
Prior art keywords
eye
patient
lacrimal
intraocular pressure
punctum
Prior art date
Application number
Other languages
English (en)
Inventor
Deepank Utkhede
Suzanne Cadden
Yong Hao
Original Assignee
Quadra Logic Tech Inc
Deepank Utkhede
Suzanne Cadden
Yong Hao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc, Deepank Utkhede, Suzanne Cadden, Yong Hao filed Critical Quadra Logic Tech Inc
Publication of IN2014DN09713A publication Critical patent/IN2014DN09713A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
IN9713DEN2014 2012-05-03 2014-11-18 IN2014DN09713A (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261642287P 2012-05-03 2012-05-03
US201261644397P 2012-05-08 2012-05-08
US201261644401P 2012-05-08 2012-05-08
US201261659921P 2012-06-14 2012-06-14
US201261680641P 2012-08-07 2012-08-07
US201261717615P 2012-10-23 2012-10-23
PCT/IB2013/000694 WO2013164671A1 (fr) 2012-05-03 2013-02-27 Système d'administration de médicament et procédés de traitement d'un glaucome à angle ouvert et de l'hypertension oculaire

Publications (1)

Publication Number Publication Date
IN2014DN09713A true IN2014DN09713A (fr) 2015-07-31

Family

ID=49514247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9713DEN2014 IN2014DN09713A (fr) 2012-05-03 2014-11-18

Country Status (7)

Country Link
EP (1) EP2844224B1 (fr)
JP (1) JP6213560B2 (fr)
CN (1) CN105473130A (fr)
CA (1) CA2872338C (fr)
HK (1) HK1222810A1 (fr)
IN (1) IN2014DN09713A (fr)
WO (1) WO2013164671A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10272040B2 (en) 2010-08-12 2019-04-30 Nanyang Technological University Liposomal formulation for ocular drug delivery
US9956195B2 (en) 2014-01-07 2018-05-01 Nanyang Technological University Stable liposomal formulations for ocular drug delivery
GB201714392D0 (en) * 2017-09-07 2017-10-25 Marsteller Laurence Methods and devices for treating glaucoma

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321108A (en) 1965-11-26 1967-05-23 William E Bowe Printing ink dispenser
US3681608A (en) 1971-03-17 1972-08-01 Us Navy Laser beam receiver having a high signal to noise ratio
US4281654A (en) 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
US4952581A (en) 1987-04-03 1990-08-28 The Trustees Of Columbia University In The City Of New York Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure
US4936008A (en) 1988-05-09 1990-06-26 Teledyne Mec Laser striping method for assembling TWT
US4934708A (en) 1988-05-20 1990-06-19 Kolkind Gerald L Family quiz board game
US5296504A (en) 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5259508A (en) 1992-08-27 1993-11-09 Beckerman Stephen M Protective shipping package
JP3002258B2 (ja) 1992-10-13 2000-01-24 アルコン ラボラトリーズ， インコーポレイテッド 緑内障（ｇｌａｕｃｏｍａ）治療のための、プロスタグランジンとクロニジン誘導体の組合わせ
US6622308B1 (en) 1999-03-23 2003-09-16 Scientific-Atlanta, Inc. Automatic digital television (DTV) bypass for a CATV converter using a CATV tuner
US6534693B2 (en) 2000-11-06 2003-03-18 Afmedica, Inc. Surgically implanted devices having reduced scar tissue formation
US7300364B2 (en) 2004-02-06 2007-11-27 Acushnet Company Multi-layer golf ball having velocity gradient from faster center to slower cover
CA2513443A1 (fr) 2003-02-26 2004-09-10 Medivas, Llc Endoprotheses vasculaires bioactives et leur mode d'emploi
JP4104137B2 (ja) * 2003-05-30 2008-06-18 有限会社エム・エル・シー 涙点プラグ
US7662864B2 (en) 2003-06-04 2010-02-16 Rutgers, The State University Of New Jersey Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent
US20050129731A1 (en) 2003-11-03 2005-06-16 Roland Horres Biocompatible, biostable coating of medical surfaces
ES2767136T3 (es) 2004-01-05 2020-06-16 Nicox Sa Derivados de prostaglandinas
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
JP2008504938A (ja) 2004-07-02 2008-02-21 レイザー，エリオット 治療媒体送出装置およびその送出装置を用いて治療媒体を眼に送り出す方法
ES2717607T3 (es) 2006-03-31 2019-06-24 Mati Therapeutics Inc Estructuras de administración de fármacos y composiciones para el sistema nasolagrimal
RU2009128703A (ru) * 2006-12-26 2011-02-10 Клт Плаг Диливери, Инк. (Us) Имплантаты, доставляющие лекарства, для уменьшения оптических дефектов
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
CN101861135A (zh) 2007-09-07 2010-10-13 Qlt栓塞输送公司 泪道植入物检测
WO2009032328A1 (fr) 2007-09-07 2009-03-12 Qlt Plug Delivery, Inc Implants lacrymaux et procédés associés
CN102670352A (zh) 2007-09-07 2012-09-19 Qlt股份有限公司 用于泪腺植入物的插入和抽出工具
JP5555162B2 (ja) 2007-09-07 2014-07-23 キュー エル ティー インク． 治療薬剤の持続放出のための薬物コア
CA2722971C (fr) * 2008-05-09 2019-05-07 Qlt Plug Delivery, Inc. Administration d'agents actifs a liberation prolongee pour traiter le glaucome et l'hypertension oculaire
AU2010206610A1 (en) 2009-01-23 2011-08-11 Qlt Inc. Sustained released delivery of one or more agents
SG174133A1 (en) 2009-02-23 2011-10-28 Quadra Logic Tech Inc Lacrimal implants and related methods
WO2011066479A1 (fr) 2009-11-27 2011-06-03 Qlt Plug Delivery, Inc. Implants lacrimaux contenant un noyau de médicament fendu et insérable

Also Published As

Publication number Publication date
JP2015520628A (ja) 2015-07-23
EP2844224A4 (fr) 2016-02-24
HK1222810A1 (zh) 2017-07-14
EP2844224B1 (fr) 2018-04-11
EP2844224A1 (fr) 2015-03-11
JP6213560B2 (ja) 2017-10-18
WO2013164671A1 (fr) 2013-11-07
CN105473130A (zh) 2016-04-06
CA2872338A1 (fr) 2013-11-07
CA2872338C (fr) 2021-09-14

Similar Documents

Publication Publication Date Title
WO2013030679A3 (fr) Administration à libération prolongée d'agents actifs pour traiter le glaucome et l'hypertension oculaire
WO2010105130A3 (fr) Système d'administration de médicament ophtalmique et applications
MX2011007804A (es) Suministro de liberación sostenida de uno o más agentes.
CA3010374A1 (fr) Reduction de la pression intra-oculaire avec des implants de bimatoprost intracamerulaires
MX2020002381A (es) Implantes intraoculares que contienen prostamida y metodos para su uso.
WO2009105690A3 (fr) Dispositifs et méthodes pour l'introduction de polynucléotides dans des cellules rétiniennes de la macula et de la fovéa
WO2010093945A3 (fr) Implant médicamenteux uvéoscléral et ses procédés d'implantation
EP2585013A4 (fr) Procédé et appareil d'intégration d'opération de cataracte avec opération de glaucome ou d'astigmatisme
PH12019500423A1 (en) Pharmaceutical composition
WO2012071476A3 (fr) Implant oculaire à élution de médicament
MX2010012022A (es) Suministro de liberacion sostenida de agentes activos para tratar glaucoma e hipertension ocular.
WO2014165308A3 (fr) Dispositif d'administration de médicament par microsphère pour libération intraoculaire prolongée
EA201590502A1 (ru) Система доставки глазного имплантата
WO2014143754A3 (fr) Implant intraoculaire contenant de la prostamide
WO2012033730A3 (fr) Bouchon méatique contenant une préparation médicamenteuse
TW200603775A (en) Anti-excitotoxic sustained release intraocular implants and related methods
WO2011084366A3 (fr) Procédés, compositions et systèmes d'administration de médicaments pour l'administration intraoculaire de molécules d'arnsi
TWD159201S (zh) 眼內鏡片植入具用鏡片保持引導具之部分
WO2011159755A3 (fr) Bouchons méatiques avec mécanisme de libération de médicament continue ou pulsée
IN2014DN09713A (fr)
MX2022002306A (es) Metodos de tratamiento de enfermedades oculares con un implante para la administracion sostenida de farmacos.
RU2010135224A (ru) Способ хирургического лечения макулярного отека после факоэмульсификации катаракты
Kishore Blurred vision and elevated IOP following intravitreal implant dislocation in an elderly patient: case report
Le Feng et al. Anatomical and functional outcomes after Densiron 68 heavy silicone oil tamponade for complicated retinal detachment in Chinese eyes
Brouzas Retinal toxicity following subconjunctival use: case report